WHO for use of polio programme resources to meet wider public

Image
Press Trust of India New Delhi
Last Updated : Jan 12 2016 | 10:42 PM IST
Countries in the South-East Asia region should optimise the resources from their polio programmes for other public health goals like immunisation, surveillance and emergency response, the WHO has said even as the region tomorrow completes five years without any case of wild poliovirus.
While lauding the achievement, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia, said there is a continued threat of poliovirus importation from the remaining polio-endemic countries.
"Completing half-a-decade without any case of wild poliovirus is an achievement. Globally, polio transmission is at its lowest-ever levels.
"However, the risk of importation of the poliovirus into all polio-free areas persists," said Singh.
She further said that efforts to keep the region polio- free have been possible due to numerous strategies that helped strengthen immunisation and disease surveillance and promote community ownership.
"While these lessons learnt are now being adopted by the remaining endemic areas, countries in the region need to replicate these strategies and optimally use the polio programme resources for other public health goals, particularly in the areas of immunisation, surveillance and emergency response.
"A polio-free world is in sight. We must continue to make efforts to rid the world of the crippling disease," she said.
WHO South-East Asia Region reported its last case of wild poliovirus in West Bengal, India, in 2011, which facilitated polio-free certification of the region on March 27, 2014.
As part of the 'Polio End Game' strategy, countries in the region are accelerating the introduction of one dose of injectable inactivated polio vaccine (IPV) in childhood immunisation schedules along with plans for a globally synchronised, phased and sequential withdrawal of oral polio vaccines from the programme.
These strategies are aimed at addressing all polio -- including the rare cases of vaccine derived polio.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 12 2016 | 10:42 PM IST

Next Story